Literature DB >> 19530747

Drug-induced changes in the T-wave morphology.

Marek Malik1.   

Abstract

Mesh：

Substances：

Year:  2009        PMID： 19530747     DOI： 10.2165/00002018-200932070-00007

Source DB:  PubMed          Journal:  Drug Saf        ISSN： 0114-5916            Impact factor:   5.606


× No keyword cloud information.
  16 in total

1.  Accurately measured and properly heart-rate corrected QTc intervals show little daytime variability.

Authors:  Marek Malik; Katerina Hnatkova; Anna Schmidt; Peter Smetana
Journal:  Heart Rhythm       Date:  2008-07-26       Impact factor: 6.343

2.  QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability.

Authors:  Velislav N Batchvarov; Azad Ghuran; Peter Smetana; Katerina Hnatkova; Monica Harries; Polychronis Dilaveris; A John Camm; Marek Malik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2002-06       Impact factor: 4.733

3.  Prolonged QT interval with halofantrine.

Authors:  E Monlun; O Pillet; J F Cochard; J C Favarel Garrigues; M le Bras
Journal:  Lancet       Date:  1993-06-12       Impact factor: 79.321

4.  Global dynamic coupling of activation and repolarization in the human ventricle.

Authors:  Arthur M Yue; Tim R Betts; Paul R Roberts; John M Morgan
Journal:  Circulation       Date:  2005-10-25       Impact factor: 29.690

Review 5.  Drug-induced torsades de pointes and implications for drug development.

Authors:  Robert R Fenichel; Marek Malik; Charles Antzelevitch; Michael Sanguinetti; Dan M Roden; Silvia G Priori; Jeremy N Ruskin; Raymond J Lipicky; Louis R Cantilena
Journal:  J Cardiovasc Electrophysiol       Date:  2004-04

6.  Changes in the pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine with concomitant administration of erythromycin.

Authors:  P K Honig; R L Woosley; K Zamani; D P Conner; L R Cantilena
Journal:  Clin Pharmacol Ther       Date:  1992-09       Impact factor: 6.875

7.  Provocation of ventricular tachycardia by antimalarial drug halofantrine in congenital long QT syndrome.

Authors:  L Toivonen; M Viitasalo; H Siikamäki; M Raatikka; S Pohjola-Sintonen
Journal:  Clin Cardiol       Date:  1994-07       Impact factor: 2.882

8.  Identifying drug-induced repolarization abnormalities from distinct ECG patterns in congenital long QT syndrome: a study of sotalol effects on T-wave morphology.

Authors:  Claus Graff; Mads P Andersen; Joel Q Xue; Thomas B Hardahl; Jørgen K Kanters; Egon Toft; Michael Christiansen; Henrik K Jensen; Johannes J Struijk
Journal:  Drug Saf       Date:  2009       Impact factor: 5.606

9.  Ventricular gradient and nondipolar repolarization components increase at higher heart rate.

Authors:  Peter Smetana; Velislav N Batchvarov; Katerina Hnatkova; A John Camm; Marek Malik
Journal:  Am J Physiol Heart Circ Physiol       Date:  2003-08-28       Impact factor: 4.733

10.  Improving the detection of subtle I(Kr)-inhibition: assessing electrocardiographic abnormalities of repolarization induced by moxifloxacin.

Authors:  Jean-Philippe Couderc; Scott McNitt; Ollivier Hyrien; Martino Vaglio; Xiajuan Xia; Slava Polonsky; Arthur J Moss; Wojciech Zareba
Journal:  Drug Saf       Date:  2008       Impact factor: 5.606
View more
  3 in total

Review 1.  Thorough QT Studies: Questions and Quandaries.

Authors:  Marek Malik; Christine E Garnett; Joanne Zhang
Journal:  Drug Saf       Date:  2010-01-01       Impact factor: 5.606

Review 2.  Assessing QT interval prolongation and its associated risks with antipsychotics.

Authors:  Jimmi Nielsen; Claus Graff; Jørgen K Kanters; Egon Toft; David Taylor; Jonathan M Meyer
Journal:  CNS Drugs       Date:  2011-06-01       Impact factor: 5.749

3.  Facts, fancies and follies of drug-induced QT/QTc interval shortening.

Authors:  Marek Malik
Journal:  Br J Pharmacol       Date:  2010-01       Impact factor: 8.739
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.